Abion
IPO- Business Model
- B2B
- Website
- abionbio.com
About
Clinical-stage biopharmaceutical company developing innovative cancer and neurological drugs
Summary
Abion is a Biotech company based in South Korea.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
$33.4M
Unknown
Similar Companies
Tiantan Biological / China Biologic (泰邦生物集团)
China's leading blood products manufacturer
Beijing, China1001–5000Biotech, Healthcare
Growth Equity·$5.1B·Aug 2022
ParexelAcquired
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Raleigh, United States10001+Biotech
Private Equity·$5.0B·Jun 2017
Simtra BioPharma Solutions
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Bloomington, United States1001–5000Biotech, Contract Manufacturing
Private Equity·$4.3B·Oct 2023
Pharmaceutical Product Development, Inc. (PPD)Acquired
Global contract research organization providing comprehensive drug development and laboratory ser...
Wilmington, United States10001+Biotech, Healthcare
Private Equity·$3.9B·Jan 2019
IVI-RMA
Global fertility clinics platform
Valencia, Spain5001–10000Biotech, Healthcare
Private Equity·$3.3B·Apr 2022
Warner ChilcottClosed
Specialty pharmaceutical company
Rockaway, United States1001–5000Biotech, Healthcare
Private Equity·$3.0B·Jan 2004